2007ABM18FDG-PET技術(shù)用于肺癌診斷和分期：臨床實(shí)踐指南
《2007ABM 18 FDG-PET技術(shù)用于肺癌診斷和分期：臨床實(shí)踐指南》內(nèi)容預(yù)覽
Fine needle aspiration (FNA) biopsy is recommended as the first-line diagnostic approach in the workup of SPN. PET should be reserved for those situations in which a biopsy is inconclusive or contraindicated
PET appears to have a high sensitivity and specificity to differentiate benign from malignant lesions as small as 1 cm in size. Lesions less than 1 cm are difficult to categorize as they lack a sufficient mass of metabolically active cells. False-negative results can occur with low-grade malignant tumours due to their lower metabolic activity or with ground-glass opacities as may be seen in bronchoalveolar carcinomas.
點(diǎn)擊下載完整版：《2007ABM 18 FDG-PET技術(shù)用于肺癌診斷和分期：臨床實(shí)踐指南》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們
聯(lián)系z(mì)lzs@120.net，我們將立即進(jìn)行刪除處理
